Literature DB >> 11895099

Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits.

Su-Lan Hsiu1, Tang-Yen Huang, Yu-Chi Hou, Der-Hang Chin, Pei-Dawn Lee Chao.   

Abstract

Naringin and naringenin are antioxidant constituents of many Citrus fruits. Naringenin is the aglycone and a metabolite of naringin. In order to characterize and compare the metabolic pharmacokinetics of naringenin and naringin, naringenin was administered intravenously and orally to rabbits, and naringin was administered orally. The concentration of naringenin in serum prior to and after enzymatic hydrolysis was determined by HPLC method. The pharmacokinetic parameters were calculated by using WINNONLIN. The results showed that the absolute bioavailability of oral naringenin was only 4%, whereas after taking the conjugated naringenin into account, it increased to 8%. When naringin was administered orally, only little naringenin and predominantly its glucuronides/sulfates were circulating in the plasma. The ratio of AUC of naringenin conjugates to the total naringenin absorbed into the systemic circulation after oral naringenin was much higher when compared to that after i.v. bolus of naringenin, indicating that extensive glucuronidation/sulfation of naringenin occurred during the first pass at gut wall. Oral dosing of naringin resulted in even higher ratio of AUC of naringenin conjugates to the total naringenin than that after oral naringenin. Our results also showed that there were great differences in pharmacokinetics of naringin and naringenin. Oral naringin resulted in latter Tmax, lower Cmax and longer MRT (mean residence time) for both naringenin and its conjugated metabolites than those after oral naringenin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895099     DOI: 10.1016/s0024-3205(01)01491-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  19 in total

1.  Sulfation of hesperetin, naringenin and apigenin by the human cytosolic sulfotransferases: a comprehensive analysis.

Authors:  Amal A El Daibani; Yuecheng Xi; Lijun Luo; Xue Mei; Chunyang Zhou; Shin Yasuda; Ming-Cheh Liu
Journal:  Nat Prod Res       Date:  2018-11-06       Impact factor: 2.861

Review 2.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

3.  Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.

Authors:  J M Huang; W Y Weng; X B Huang; Y H Ji; E Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

4.  Identification of Naringin Metabolites in Human Urine and Feces.

Authors:  Xuan Zeng; Yang Bai; Wei Peng; Weiwei Su
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

5.  Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.

Authors:  Feng-Lin Yen; Tzu-Hui Wu; Liang-Tzung Lin; Thau-Ming Cham; Chun-Ching Lin
Journal:  Pharm Res       Date:  2008-11-25       Impact factor: 4.200

6.  Prevention of disuse muscle atrophy by dietary ingestion of 8-prenylnaringenin in denervated mice.

Authors:  Rie Mukai; Hitomi Horikawa; Yutaka Fujikura; Tomoyuki Kawamura; Hisao Nemoto; Takeshi Nikawa; Junji Terao
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

7.  Preparation and Characterization of Naringenin-Loaded Elastic Liposomes for Topical Application.

Authors:  Ming-Jun Tsai; Yaw-Bin Huang; Jhih-Wun Fang; Yaw-Syan Fu; Pao-Chu Wu
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

8.  Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats.

Authors:  Shiuan-Pey Lin; Yu-Chi Hou; Shang-Yuan Tsai; Meng-Ju Wang; Pei-Dawn Lee Chao
Journal:  Biomedicine (Taipei)       Date:  2014-08-13

9.  Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability.

Authors:  Lirong Zhang; Xiaohua Xu; Tiechao Jiang; Kunzhe Wu; Chuanbo Ding; Zhen Liu; Xuanhe Zhang; Tianhua Yu; Changlong Song
Journal:  Oxid Med Cell Longev       Date:  2018-02-07       Impact factor: 6.543

10.  Polymeric micelles for potentiated antiulcer and anticancer activities of naringin.

Authors:  Elham Abdelmonem Mohamed; Irhan Ibrahim Abu Hashim; Rehab Mohammad Yusif; Ahmed Abdel Aziz Shaaban; Ahmed Ramadan El-Sheakh; Mohammed Fawzy Hamed; Farid Abd Elreheem Badria
Journal:  Int J Nanomedicine       Date:  2018-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.